Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence
- PMID: 31479634
- DOI: 10.1016/j.ajog.2019.08.045
Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence
Abstract
Human papilloma virus is the primary causative agent for cervical cancer, and vaccination is the primary means of preventing anogenital cancers caused by human papilloma virus infection. Despite the availability of human papilloma virus vaccines for more than a decade, coverage rates lag behind those for other vaccines. Public concerns regarding safety of human papilloma virus vaccines have been identified as an important barrier to vaccination, including concerns that the human papilloma virus vaccine may cause primary ovarian insufficiency, driven in part by isolated reports of ovarian failure following the human papilloma virus vaccine. We summarize published peer-reviewed literature on human papilloma virus vaccines and primary ovarian insufficiency, reviewing information contained in the case reports and series. Healthcare providers should address any patient concerns about primary ovarian insufficiency and the human papilloma virus vaccine by acknowledging the case reports but noting the lack of association found in a recently published epidemiologic study of approximately 60,000 female individuals. Current evidence is insufficient to suggest or to support a causal relationship between human papilloma virus vaccination and primary ovarian insufficiency.
Keywords: human papilloma virus vaccination; premature ovarian failure; primary ovarian insufficiency.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis.Curr Opin Obstet Gynecol. 2015 Aug;27(4):265-70. doi: 10.1097/GCO.0000000000000183. Curr Opin Obstet Gynecol. 2015. PMID: 26125978 Review.
-
Authors' reply: Human papilloma virus vaccine and primary ovarian failure.Am J Reprod Immunol. 2014 Sep;72(3):260-1. doi: 10.1111/aji.12286. Epub 2014 Jul 1. Am J Reprod Immunol. 2014. PMID: 24981881 No abstract available.
-
On the relationship between human papilloma virus vaccine and autoimmune diseases.Autoimmun Rev. 2014 Jul;13(7):736-41. doi: 10.1016/j.autrev.2014.01.054. Epub 2014 Jan 24. Autoimmun Rev. 2014. PMID: 24468416 Review.
-
Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.Am J Reprod Immunol. 2013 Oct;70(4):309-16. doi: 10.1111/aji.12151. Epub 2013 Jul 31. Am J Reprod Immunol. 2013. PMID: 23902317 Review.
-
Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination.BMJ Case Rep. 2012 Sep 30;2012:bcr2012006879. doi: 10.1136/bcr-2012-006879. BMJ Case Rep. 2012. PMID: 23035167 Free PMC article.
Cited by
-
OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines.Heliyon. 2022 Nov 11;8(11):e11515. doi: 10.1016/j.heliyon.2022.e11515. eCollection 2022 Nov. Heliyon. 2022. PMID: 36411908 Free PMC article.
-
Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination.Sci Adv. 2022 Jul 15;8(28):eabm7201. doi: 10.1126/sciadv.abm7201. Epub 2022 Jul 15. Sci Adv. 2022. PMID: 35857495 Free PMC article.
-
The influence of parent-child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey - Teen, 2010-2019.Hum Vaccin Immunother. 2022 Nov 30;18(5):2086762. doi: 10.1080/21645515.2022.2086762. Epub 2022 Jul 7. Hum Vaccin Immunother. 2022. PMID: 35797721 Free PMC article.
-
Early Cervical Lesions Affecting Ovarian Reserve and Reproductive Outcomes of Females in Assisted Reproductive Cycles.Front Oncol. 2022 Mar 21;12:761219. doi: 10.3389/fonc.2022.761219. eCollection 2022. Front Oncol. 2022. PMID: 35387117 Free PMC article.
-
Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure.Front Pharmacol. 2022 Jan 28;13:810524. doi: 10.3389/fphar.2022.810524. eCollection 2022. Front Pharmacol. 2022. PMID: 35153783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical